Trupanion (NASDAQ:TRUP) CEO Margaret Tooth Sells 978 Shares

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 978 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90. Following the completion of the transaction, the chief executive officer owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. This trade represents a 0.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

• On Monday, May 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $21.86, for a total value of $10,733.26.

Trupanion Stock Up 2.2%

Shares of NASDAQ TRUP opened at $31.00 on Friday. The stock has a market cap of $1.36 billion, a P/E ratio of 58.49, a PEG ratio of 2.18 and a beta of 1.39. The business’s fifty day simple moving average is $25.38 and its 200-day simple moving average is $26.08. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $50.06. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. During the same period in the previous year, the firm posted $0.22 EPS. Trupanion’s revenue for the quarter was up 11.1% on a year-over-year basis. As a group, equities analysts predict that Trupanion, Inc. will post 0.59 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on TRUP. Weiss Ratings raised Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday. Stifel Nicolaus set a $28.00 price target on shares of Trupanion in a research note on Friday, June 26th. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Finally, Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $41.60.

Institutional Trading of Trupanion

Institutional investors have recently bought and sold shares of the business. Kelleher Financial Advisors acquired a new position in shares of Trupanion during the 2nd quarter worth about $42,000. Parallel Advisors LLC raised its position in shares of Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after acquiring an additional 1,722 shares in the last quarter. Kemnay Advisory Services Inc. acquired a new stake in shares of Trupanion during the 4th quarter worth about $64,000. Quantbot Technologies LP purchased a new stake in Trupanion during the second quarter worth approximately $89,000. Finally, Advisory Services Network LLC purchased a new stake in Trupanion during the third quarter worth approximately $160,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.